In triple-negative breast cancer (TBNC), TMAO induced pyroptosis in tumor cells by activating the endoplasmic reticulum stress kinase PERK, enhanced CD8 T cell-mediated antitumor immunity in vivo, and correlated with improved efficacy of immunotherapy [178]. The gene discussed is CD8A; the disease is neoplasm.